SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: HGR - Undervalued at 15 ( acquired novacare/will 2x reven

No earlier versions found for this Subject.


Return to HGR - Undervalued at 15 ( acquired novacare/will 2x reven
 
HGR-

yearly low of 12 and change currently trading at 15.. Announced yestereday they acquired novacares's prosthetic unit. This acquistion will double their revenue. 52 week high is around 27.. Stocks earnings and revenue are expected to grow 30%. Company before this acquistion had little to no debt..

lets talk..

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News